Your Expert Guide to Developing Psychoactive Substances
Practical Approaches to Conducting
Early Clinical Trials with Psychedelics
Watch this on-demand webinar on the development of psychedelics. Altasciences’ experts, Dr. Setnik and Dr. Milovan, provide an overview of the pragmatic and cost-effective approaches to conducting early-phase clinical trials with psychedelics, including adequate setup of the clinical pharmacology unit.
Speak with our experts to discuss your drug development needs.
You may also be interested in the following:
Scientific Journal: Challenges Associated with Schedule I Therapeutic Development
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.